Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Executive Insight strengthens UK presence with new partner

David Ewbank joins the firm from McCann Health

- PMLiVE

Redefining the real value within a good value proposition

Successful value propositions

- PMLiVE

Boosting pharma’s metabolic rate

How using more diversity at the top can speed-up change

- PMLiVE

Achieving deep understanding of healthcare customer behaviour

In part one of a series on customer insight and behaviour change, Martine Leroy reveals a behaviour framework for gathering sharp insights used to help brand managers and marketers achieve...

Blue Latitude Health

- PMLiVE

Random42 celebrates at Cannes Corporate 2017

Wins gold dolphin award for Defending LIfe: The Immune Ecosystem

- PMLiVE

Shire’s gene therapy candidate receives orphan drug status in the US

Investigational factor VIII treatment SHP654 is being developed for haemophilia

- PMLiVE

CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

US advisors recommend GSK's shingle vaccine be used instead of Merck's rival product

- PMLiVE

McCann Health expands its Manchester footprint

Complete Medical Communications and Complete HealthVizion are set to double their capacity in the city

Roche Basel Switzerland

Roche biggest pharma R&D spender in PwC survey

Pharma giant on track to spend 21.9% of its total revenue on research this year

- PMLiVE

Lilly mulls divestment of its animal health operations

Pharma firm is due to make a final decision on Elanco in 2018

- PMLiVE

Alexion’s Soliris gets US approval for myasthenia gravis

New neurology indication could contribute $1.2bn to sales, says analysts

- PMLiVE

Gilead wins European approval for triple hep C combination Vosevi

The treatment brings together sofosbuvir, velpatasvir and voxilaprevir

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links